EMEA-000876-PIP01-10-M01
Key facts
Invented name |
Soliris
|
Active substance |
Eculizumab
|
Therapeutic area |
Immunology-Rheumatology-Transplantation
|
Decision number |
P/0290/2014
|
PIP number |
EMEA-000876-PIP01-10-M01
|
Pharmaceutical form(s) |
Concentrate for solution for infusion
|
Condition(s) / indication(s) |
|
Route(s) of administration |
Intravenous use
|
Contact for public enquiries |
Alexion Europe SAS
France |
Decision type |
PM: decision on the application for modification of an agreed PIP
|